glucagon like peptide-2
Peptideexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2012 (NCT01573286)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
GLP2R agonist
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- glucagon like peptide-2
- glucagon like peptide-2
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03954873 | N/A | Jan 31, 2019 | University of Copenhagen |
| NCT01573286 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2012 | University of Alberta, University of British Columbia, University of Calgary, University of Toronto |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Alberta | Academic/Hospital | 1 | 0 | 1 | 2012 |
| University of British Columbia | Academic/Hospital | 1 | 0 | 1 | 2012 |
| University of Calgary | Academic/Hospital | 1 | 1 | 1 | 2012 |
| University of Copenhagen | Academic/Hospital | 1 | 1 | 1 | 2019 |
| University of Toronto | Academic/Hospital | 1 | 0 | 1 | 2012 |
5 organizations
Page 1 / 1